MICROSCOPIC POLYANGIITIS
Clinical trials for MICROSCOPIC POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new MICROSCOPIC POLYANGIITIS trials appear
Sign up with your email to follow new studies for MICROSCOPIC POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood Test-Guided dosing could spare patients unnecessary infusions
Disease control CompletedThis study tested whether giving the drug rituximab only when blood markers (ANCA and CD19 cells) rise is as good as giving it on a fixed schedule to prevent relapses in people with ANCA-associated vasculitis. 166 adults who were already in remission took part. The goal was to se…
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 07:11 UTC
-
Are cheaper versions of a key vasculitis drug just as safe and effective?
Disease control CompletedThis study looked at 201 Canadian patients with ANCA-associated vasculitis to see if biosimilar versions of rituximab work as well as the original drug. Researchers tracked disease control, side effects, and how long it took to get insurance approval for treatment. The goal is to…
Matched conditions: MICROSCOPIC POLYANGIITIS
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 26, 2026 07:01 UTC
-
Can a single drug keep rare blood vessel disease at bay?
Disease control CompletedThis study looked at whether rituximab can help people with a rare autoimmune disease called ANCA-associated vasculitis stay in remission longer than the standard treatment, azathioprine. 117 adults who were already in remission took either rituximab or azathioprine for 18 months…
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Could a tiny dose of an alcoholism drug ease vasculitis pain?
Symptom relief CompletedThis study tested whether a very low dose of naltrexone, a drug already approved for alcoholism, can improve physical health and quality of life in people with vasculitis (a group of rare diseases causing blood vessel inflammation). Sixty adults with different types of vasculitis…
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 26, 2026 07:02 UTC